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Genetic modified maize crop increases annually as a result of food insecurity and limited land caused 
by rapid population increase of over seven billion in the world. Scientists have been playing their role to 
address this food insecurity problem. The use of genetically modified (GM) maize crop to feed people is 
one of the proposed ways, because it yields more compared to the conventional varieties. However, 
there are several contradictions which hinder the adoption of this new technology. Some studies have 
shown that GM maize is risky to human health, animals and not friendly to environmental conservation, 
which may lead to the death of other bio-diversities. Generally, other studies have supported the 
consumption of GM maize. However, after being approved by the scientist in the countries concerned, 
the GM maize varieties which seem to be hazardous to human health must be prohibited in research 
centres so as to avoid transportation to other countries. Regarding the new technology of GM maize, 
the conventional method of breeding is still important to keep maize seeds available in the gene bank. 
Therefore, researchers should consider this for further research issues on maize improvement. 
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Genetically modified (GM) maize ranked the second most 
important transgenic crop globally. It is planted in an area 
that accounts for 24% of global biotech crop area and 
about 14% of total maize grown globally (James, 2005). 
Farmers have rapidly adopted genetically modified 
organism (GMO) technology including GM maize crops 
(Lawson et al., 2009). GMO technology involves the 
incorporation of genetic engineering to improve crop 
productivity since over one billion people in the world face 
starvation and two billion people suffer from one or more 
micronutrient deficiencies, especially vitamin A, iodine 
and iron, often lumped as hidden hunger (Alnwick, 1996). 
The technology has been adopted by most of the 
developed countries which previously were not aware of 
it. GM crops are also used for food security purpose 
(Chondie and Kebede, 2015). GM crops were first grown 
commercially worldwide in 1996 (James, 2007). Due to 
the advancement of biotechnology, a number of GM or 
transgenic crops carrying novel traits have been 
developed and released for commercial purpose (Arthur, 
2011). In GM maize crops technology, the desired traits 
are inserted into plant, unlike the conventional breeding 
methods, where traits from two crops are combined; for 
instance,  maize   crops   (James,   2013;   Chondie   and  
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Table 1. Genetically modified maize crop development in sub-Saharan Africa (Namuddu and 
Grumet, 2013). 
 
Country Crop/Trait Status 
Kenya 
Maize/Stem borer resistance Confined field trials 
Maize drought tolerance Confined field trials 
   
Mozambique Maize/Drought tolerance Stalled: awaiting regulatory framework 
   
South Africa 
Maize streak virus resistance Greenhouse containment 
Maize/Drought tolerance Greenhouse containment 
   
Tanzania Maize/Drought tolerance Stalled: awaiting regulatory framework 




Kebede, 2015). GM maize is useful for livestock and 
human consumption (Clive, 2008).  
Resistance to herbicide as well as insect is the most 
common trait that has been incorporated into GM maize. 
GM crops contain proteins that make them herbicide 
tolerant (Ht) and insect resistant (USDA, 2011). Herbicide 
tolerant crops are engineered to produce one or more 
proteins which allow them to survive even if sprayed with 
herbicides (Carman et al., 2013). A number of studies 
conducted have shown a significant number of GM crops 
which are approved for human and animal use. Crops 
containing several GM genes 'stacked' into one plant are 
among the recommended for consumption (Carman et 
al., 2013). GM maize varieties are common in some 
countries like United States of America (USA) (USDA, 
2011). The GM maize from USA contains Ht or Bacillus 
thuringiensis traits, or a „stacked‟ combination of them 
(Pioneer Hi-Bred, 2012). Of this, 2004 GMO technology 
accounted for 23% of all GM crops produced (James, 
2004). It has been projected that in the coming decades, 
human population will reach over nine billion (Pinstrup-
Andersen, 2010a, b). Therefore, the production of GM 
maize should not be stopped so as to make the new 
approved beneficial traits available to people (James, 
2007). The common producers of GM maize globally are 
dominated by USA having 59% of land for production, 
followed by Argentina with 20%, Canada and Brazil with 
6% each, and China with 5% of land. GM maize is in the 
initial stage in Africa (Moola and Munnik, 2007). Of all 
countries in African, only South Africa and Egypt have 
introduced new commercialized GM maize. However, 
Zimbabwe, Kenya, Nigeria, Mali, Egypt, and Uganda 
have also adopted GM maize in Africa. Other countries 
are still engaging in GM research, whereas others are in 
trials including Benin, Burkina Faso, Cameroon, Ghana, 
Malawi, Mauritius, Morocco, Namibia, Niger, Senegal, 
Tanzania, Tunisia, and Zambia (Moola and Munnik, 
2007). Table 1 shows some of the GM crops under 
research in sub Saharan Africa. 
Several studies on GM maize have been done to either 
introduce herbicide-tolerance (for instance Roundup (R)) 
or to produce a modified B. thuringiensis toxin insecticide 
or both (Seralini et al., 2014). Results have shown that 
these GM crops contain new pesticide residues for which 
new maximum residue levels (MRL) have been 
established in some countries. However, herbicide 
(glyphosate) tolerance and B. thuringiensis toxins make 
crop plants inedible to some insects (GineBordonaba, 
2011; Hammond et al., 2006). It has been reported that 
no major physiological changes are attributable to the 
consumption of GM maize in sub-chronic toxicity studies 
(GineBordonaba, 2011; Hammond et al., 2006). GM 
maize crop has offered some solutions to future food 
production. According to Tirado and Johnston (2010), 
although solutions to food have been provided by GM 
maize, there has been increase in farmers‟ dependence 
on agro-industries compared to non-GM maize seed 
which farmers believe to be safe with less cost. An 
example of GM maize crop which has been approved for 
cultivation in Europe is MON 810 maize (Monsanto). It 
contains a Cry gene from the bacterium B. thuringiensis, 
which expresses B. thuringiensis protein, a toxin of 
insecticidal properties (Tirado and Johnston, 2010). Most 
European countries have banned the cultivation of GM 
maize, because biotechnological industries are not 
interested in introducing GM varieties resistant to 
drought, soil salinity, and cold due to their low marketing 
potential (Lisowska, 2011). Therefore, this review paper 
aims to explore the constraints, benefits, risk to human 
and animals‟ health and environment as well as the 
controversy of GM maize. 
 
 
CONSTRAINTS OF GM MAIZE CROP 
 
Studies about GM maize were reported for the first time 
in Africa through food aid shipments which were given in 
Southern Africa during the food crisis that occurred in 
2002 (Zerbe, 2004). New GM technology is introduced 





factors including climate change, limited arable land, 
water shortage, pests and diseases, debt, collapsing 
public services, and poor governance (ISF, 2011). 
However, Africans were not happy with GM maize. They 
debated against agricultural biotechnology, refusing to 
use GM products (Zerbe, 2004). Although GM maize 
prevents hunger, its safety has not been proved in any 
documents. Therefore, the countries which oppose GM 
maize could be correct to maintain health status (Konig et 
al., 2004; Seralini et al., 2009). Rats fed with the genetic 
modified maize (NK 603, MON 810, and MON 863), 
revealed 3 new GMOs side effects, which were sex and 
often dose-dependent (Spiroux de Vendômois et al., 
2009). More side effects were observed in kidney and 
liver, the dietary detoxifying organs (Spiroux de 
Vendomois et al., 2009). It has been estimated that GM 
maize crop is taken up quickly than any other agricultural 
technology which is currently used by 16 million farmers 
(James, 2007). Maize imports from United States and 
Mexico seem to be worse in terms of subsistence 
farmers‟ trade. Hence, the production has been reported 
to decrease due to the loss of local varieties of maize and 
this would lose their resilience to environmental stress 
through contamination with genetically modified maize 
(Zietz and Seals, 2006). 
European Corn Borer (ECB) is one of the major pests 
that have been affecting maize (corn) crops in North 
America for over 60 years (Park et al., 2011). The pest 
was controlled by dichlorodiphenyltrichloroethane (DDT) 
which later had negative effects; therefore, it was 
rejected. Organophosphate and pyrethroids were 
subsequently used (Park et al., 2011). The strains with 
high resistance to European corn borer were developed 
by plant breeders. The mixture showed success with 
transgenic maize expressing insecticidal protein derived 
from B. thuringiensis (Kaster and Gray, 2005). Avidin, 
produced commercially in GM maize for use in research 
and diagnostics, is toxic to certain insects (Park et al., 
2011).  There are also environmental issues relating to 
gene flow from GM crops to non-GM crops which may 
disturb genotypes and lower production. Further studies 
are needed to confirm the usefulness of GM maize to 
avoid risk to human and animals (Park et al., 2011). Left-
over grains from GM maize modified to express 
biopharmaceutical compounds have been reported to 
germinate with soybeans grown on the same field in the 
season following the trial. This may cause contamination. 
GM maize technology has affected seed markets. An 
agrochemical company, Monsanto which has not been 
registered as traditional breeder, took advantage of seed 
production during the establishment of genetic 
engineering. The company made patents and use an 
opportunity to access the market and implement new 
strategies to obtain maximum profit (Vandana et al., 
2011). Prices for seeds are increasing and the number of 
farmers using seeds from their own harvest is being 
endangered steeply and may likely disappear  completely  




(Jacobsen et al., 2013).  
 
 
BENEFITS OF GM MAIZE CROP 
 
Genetic modified crops may provide better quality food, 
higher nutritional yields, inexpensive and nutritious food, 
crops and produce that require less chemical application, 
such as herbicide resistant maize. Previously, GM maize 
was grown for commercial purpose in 11 countries, 
including United States, Brazil, Argentina, South Africa, 
Canada, Philippines, and Spain (Singh et al., 2014). 
From the African perspective, GM technology so far has 
been deployed only in South Africa, Zimbabwe, Egypt, 
Kenya, Burkina Faso, Uganda, Malawi, and Mauritius. Of 
these, few countries, South Africa, Egypt, and Burkina 
Faso have commercialized their crops (Arthur, 2011; 
ASSAF, 2010). Since its introduction, GM technology has 
been found to reduce losses of maize incurred through 
damage by stem borers (Wanyama et al., 2004) and 
reduce herbicides application by introducing B. 
thuringiensis maize through transgenesis. B. thuringiensis 
maize used is of a better grain quality, and increases 
farmers‟ competitiveness; a healthier product, like 
mycotoxin is consistently well below mandatory 
regulations (Barros et al., 2009). Enrichment of transgenic 
maize in specific alimentary products makes such maize 
foods to frequently have higher utility value than 
traditional food products. The group of nutraceutics 
contains, first of all, vitamins A, C, E, plant pigments, 
alimentary cellulose, and pre- and probiotics (Kosicka-
Gębska et al., 2009). The leading examples of cultivable 
edible vaccines are exemplified by varieties of rice, 
maize, soybean or potato, capable of producing antigens 
against various infections, including the effects of 
Escherichia coli toxins, rabies, infections of Helicobacter 
pyloribacteria, and viral type B hepatitis (Kramkowska et 
al., 2013). Several studies have reported that the 
reduction of pest damage after the introduction of B. 
thuringienssis maize instead of conventional maize 
results in enhanced yield (Huesing and English, 2004). At 
commercial level, after the approval of the glyphosate-
tolerant soybeans, other twenty events have been 
approved for planting, food and feed consumption and 
commercialization, including 15 maize varieties. Gouse et 
al. (2005) found that large-scale commercial maize 
farmers benefit economically from the use of insect 
resistant yellow maize. Despite paying more for seeds, 
farmers who adopted B. thuringiensis yellow maize unlike 
conventional maize had increased income through 
savings from pesticides and increased yield due to better 
pest control (Huesing and English, 2004). Corn has been 
deliberately genetically modified to establish agrono-
mically desirable traits. Traits that have been engineered 
into corn include resistance to herbicides and resistance 
to insect pests, the latter being achieved by incorporation 
of a gene that codes for the B. thuringiensis  toxin  (Singh 




et al., 2014). GM maize varieties with high resistance to 
glyphosate herbicides have been produced. Pioneer Hi-
Bred marketed corn hybrids with tolerance to imidazoline 
herbicides under the trademark “Clearfield” beng in 
Canada markets. Though in these hybrids, the herbicide-
tolerance trait was bred without the use of genetic 
engineering. Therefore, these corn hybrids do not apply 
imidazoline-tolerant corn (Singh et al., 2014). The 
utilization of pesticides and herbicides globally has 
decreased. The decrease is due to the emergence of GM 
maize technology. However, there may be some 
variations of response from one variety to another 
(Benbrook, 2012). This has contributed to increase of 
agricultural production (Phipps and Park, 2002). However, 
Phipps and Park (2002) have established that the use of 
B. thuringiensis maize has the added advantage of 
reducing mycotoxin contamination, thus producing safer 
grain for both human and animals. In addition, B. 
thuringiensis -maize seeds have been distributed as new 
improved varieties which give high yields, thus consumers 




CONTROVERSY OF GM MAIZE CROP 
 
Regarding the high emphasis placed on innovation of 
technology in plant breeding especially GM maize crop 
which has expanded recently, there has been a debate 
about global food production focusing on GM crops, 
safety and regulatory approval process of GM crops and 
foods (Konig et al., 2004; Seralini et al., 2009). Many 
studies have been documented that, the countries which 
emphasize use of GM maize crop are often times more 
concerned about making profit first than health care 
(Seralini et al., 2014). Some scientists are against GM 
maize consumption; they have supporting evidence 
which shows that GM maize affects biodiversity leading 
to reduction of living organisms in the environment. 
Scientists are advised to carry out more research works 
so that they come up with effective conclusion about GM 
maize (Buiatti et al., 2013). This perspective is similar 
with Phipps and Park (2002) who stated that the 
sequencing of genomes provides capacity for selective 
breeding of crops suited to diverse ecologies including 
GM maize crop. Whilst scientists continue to debate 
risks, such as the effects of genetically engineered maize 
pollen on butterfly populations, drastic reductions in 
pesticide use achieved through the introduction of GM 
crops need to be researched (Ortiz et al., 2014). On the 
other hand, its adverse effects on the environment and 
human health have not  been known for a decade. There 
are on-going researches which may come up with proper 
conclusion of whether to use GM maize or not (Buiatti et 
al., 2013). Spain, one of the countries which have 
adopted GM maize production technology, has been 





yield (James, 2008). Transgenic imidazolinone resistant 
maize is resistant to pest leading to the improvement of 
yield. However, the pest affected areas continue to 
spread northwards (Park et al., 2011). In other countries, 
for instance, Poland has allowed GM maize crop where 
B. thuringiensis maize has been commercially grown 
since 2006. However, other countries are in the first trial; 
for instance, Tanzania, Malawi, Ghana, and Uganda 
(Ortiz et al., 2014). The GM maize feed in Tanzania is in 
restriction awaiting approval from the government (Ortiz 
et al., 2014). Use of GMO feeds in Poland was permitted 
occasionally until the year 2012 (Maciejczak and Wąs, 
2008). There is on-going debate at different levels 
regarding introduction of GMO crops in Poland. However, 
most public opinion shows that half of Polish society does 
not allow the introduction of GMO cultivations (Maciejczak 
and Wąs, 2008). B. thuringiensis gene, isolated from B. 
thuringiensis bacteria is considered resistance for the 
transgenesis of maize (Ronald, 2011). 
It is assumed that a toxin coded by a bacterial 
chromosome, after transferring to plant tissues, allows 
the development of resistance to noxious insects which 
reduce crops, but have no negative influence on the 
health of humans and animals consuming the plants 
(Twardowski, 2010). This procedure proves that, the GM 
maize is resistant to corn borer (Pyrausta mirilabilis), 
while its commercial variety (MON810) is used for 
cultivation worldwide, including Poland and other 
countries of the European Union (Kramkowska et al., 
2013). A similar report was documented by Stephenson 
(2010) that MON810 Monsanto‟s line of maize was 
developed through genetic modification to resist corn 
borer, an insect pest in Europe. Other countries like 
Spain have planted MON810 without experiencing 
negative effects (Stephenson, 2010). European Food 
Safety Authority (EFSA)‟s findings indicate that MON810 
(Monsanto pesticide produce GM maize) is environ-
mentally safe (Stephenson, 2010).  One of the diseases 
which forced scientists to adopt GM maize crop is the 
maize streak virus (MSV) of Zea mays L. This has made 
the production of maize in some parts of Africa virtually 
impossible, leading to critical food insecurity (Bosque-
Perez, 2000). Arthur (2011)‟s argument is against GM 
maize crop, because it affects value of maize genetic 
resources of landraces in the centre of crop diversity. 
Germany‟s law allows the banning of a GMO product if it 
potentially poses harm to the environment. Other 
countries should adopt the Germany‟s law to keep the 
environment useful for other living organisms 
(Stephenson, 2010). Southern African countries in 2001 
rejected GM food aid from the U.S during a severe 
drought partly due to environmental concern. Scientists 
generally agreed that the possibility of actual potential 
environmental risk due to pollen disbursal is extremely 
remote (Stephenson, 2010).  
For GM maize technology to be adopted in a number of 





Aventis, the American producer of maize given the utility 
name of Star Link maize (Kramkowska et al., 2013). The 
modified plant contained an additional gene, conditioning 
natural resistance to pesticides (Benbrook, 2012). The 
transfer of genetic information from B. thuringiensis 
bacteria to the cell nuclei of maize yielded the expression 
product of Cry9c protein, which produced strong allergic 
properties (Kramkowska et al., 2013). Due to its 
specificity, Star Link maize gained the acceptance of the 
Environmental Protection Agency (EPA) and was 
permitted to enter the trade market exclusively as an 
animal fodder (Ramjoue, 2008). However, after 
commercialization of the transgenic plant, Star Link 
maize was detected in food products generally accessible 
in consumer markets (Ramjoue, 2008). In other study 
with high widespread press coverage, GM Star link maize 
which was approved for animal feed but not for human 
consumption was found unsafe for human consumption 
(Oliva et al., 2006). Spread of the information through 
mass media was followed by numerous consumers‟ 
reports  related to symptoms of food allergy in the form of 
headache, diarrhoea, nausea and vomiting, which were 
supposed to develop following consumption of products 
containing the GM maize (Domingo, 2007; Dona and 
Arvanitoyannis, 2009; Batista and Oliveira, 2009). Before 
the release of GM maize crop, sufficient research should 
be conducted such that the recommendation on the use 
of new GM maize variety should not result in health risk 
to human, animals and environment in order to prevent 
biodiversity depletion (Ortiz et al., 2014). Countries which 
are in trial with GM maize crop should make laws which 
govern the use of GM maize. This will help to checkmate 
companies which aim to make profit by selling GM maize 
without considering the health risk involved (Ortiz et al., 
2014).  
Other reports are against the findings which emphasize 
MON810 maize to be safe for human and animal 
consumption. For instance, Kramkowska et al. (2013) 
reported harmful influences of MON810 maize (resistant 
to corn borer) on cells of the pancreas, intestines, liver 
and kidneys in rodents. Based on several European 
Union Member States‟ suggestion of provisional 
restriction or prohibition of marketing maize MON 810 in 
their territory, the EFSA GMO Panel concluded that, 
there is no scientific proof of  health risk  to human, 
animal and environment (EFSA, 2012) in using MON 
810.  
Rossi et al. (2011) noted positive evidence that piglets 
given maize MON 810 performed better than piglets 
given the control maize. They suggested that this 
difference was due to the lower level of fumonisin B1 in 
the diet. These additional feeding studies are good 
confirmations that maize MON 810 has no health risk to 
animals as other recommended maize for animal feed 
(EFSA, 2012). Results of other studies have shown the 
effects of different varieties of transgenic maize (MON810 
and MON863) on living bodies. They showed  that  maize  




producing B. thuringiensis toxin is resistant to insects, 
NK603 and roundup herbicide, which has the potential to 
induce histopathological lesions first of all in liver and 
kidneys, and thus, in the principal detoxifying organs 
(Spiroux de Vendomois et al., 2010). This report has 
been confirmed in experiments involving two groups of 
rats: one group fed for 90 days with 11 or 33% 
components of transgenic maize and the control group 
which was given non-GM maize. However, Spiroux de 
Vendomois et al. (2009),  in their previous study, 
suggested that, the chronic toxic effects of GM maize 
effect should finalized after long term evaluation for at 
least two years instead of three months.  
Studies on similar crop by other authors agreed with 
previous findings: in South Africa markets, there is a 
significant reduction in pesticide use due to the 
availability of GM maize with better resistance to stem 
borer insect (Chondie and Kebede, 2015). Such varieties 
include B. thuringiensis maize that are already helping 
farmers in other African countries such as South Africa, 
Egypt and Burkina Faso (Chondie and Kebede, 2015). 
The common GM crops of research and commercial 
interest in Africa are maize, cotton, soybean, pigeon pea, 
banana, sweet potato and tobacco (Zerbe, 2004). Of 
these, trials have been conducted in various countries. 
Though, in Africa, only four countries (Burkina Faso, 
Egypt, South Africa and Sudan) are growing transgenic 
crops out of a total of 29 worldwide (Chondie and 
Kebede, 2015). The policies and legislation in place do 
not seem to cater for transgenic livestock research and 
deployment of livestock transgenic animals (Kiome, 
2015). The studies on crops like livestock transgenic 
research in Africa are very weak only in African countries 
which have practiced transgenic research on livestock. 
However, no clear information has been displayed 
(Kiome, 2015). Chondie and Kebede (2015) also 
suggested that before any interventions be done in the 
GM crops in African countries, farms must be tested for 
GM crops by researchers to avoid potential risks. 
Furthermore, policy makers and researchers should 
evaluate environmental and socioeconomic risks, for 
instance, risks to biodiversity, the prospects of insufficient 
out-crossing distances, the relative absence of clear 
labelling and other threats to seed purity from adjacent 
traditional food production. This should be done before 
farmers change their conventional farming methods to 
GM (Azadi and Ho, 2010). Research centres must 
preserve the local landrace strains of maize for food 
security through seed saving. They should be confined in 
the gene bank in order to prevent genetic loss and 
transgenic contamination of the local landraces (Chondie 
and Kebede, 2015). John and Beringer (2000) believed 
that GM maize does not present a measurable risk to 
humans. In addition, the authors do not agree with 
statement that Novartis should persevere with a crop that 
is so widely perceived to be a threat to human health 
(John and Beringer, 2000) and whose construction  is  so  




obviously awed from a public point of view. Moreover, 
there is clear evidence that GM maize is not easily 
contaminated by mycotoxins such as fumonisin and 
aflatoxin, toxins produced by fungi that infest maize cobs 
and which cause serious illnesses in man and animals 
(DeVilliers and Hoisington, 2011). With the exception of 
GM cotton, soybean and maize, only a limited number of 
commercially available GM crops are currently suitable 
for conditions in developing countries. Even though GM 
maize crop is promoted for high yield worldwide, Gurian-
Sherman (2009) indicated that there is a strong market to 
grow non‐GMO corn for the premiums in Kentucky 
compared to GM maize product. GM maize crop has 
contributed to lower its production in the United States 
(Gurian-Sherman, 2009). In contrast, Lee and Halich 
(2008) argued that farmers are concerned that they may 
be losing yield without using GMO hybrids because their 
finding showed that GMO hybrid yield was higher than 
the non‐GMO sister at a range of 2.5 to 25.5 ratios. More 
similar studies need to be conducted to compare non‐GM 
maize/GM maize pairs in the future to determine if these 
differences are consistent across a larger number of 
hybrids (Lee and Halich, 2008). 
For subsistence farmers, for instance in parts of Africa, 
toxins also cause grave health problems, particularly for 
children. Mycotoxin contamination of GM maize may be 
reduced by preventing injuries to maize cobs (DeVilliers 
and Hoisington, 2011). One among the disadvantages of 
GMO is the inability of the farmers to save GM maize 
seed since harvested grains cannot be used as farmer-
saved seed. This has been one of the critics of 
biotechnology which is often given as a reason why in 
African countries B. thuringiensis seeds are not suitable 
for smallholder farmers who mostly use farmer-saved 
seeds due to low income (DeVilliers and Hoisington, 
2011). Previously, 70% of maize donated to Southern 
Africa in mid-2002 from United States was GM (Cooke 
and Downie, 2010). Zambia, along with Zimbabwe, 
Mozambique, and Malawi refused the food donated and 
in Zambia, about 18,000 tons of donated maize already in 
the country was put under security and ultimately 
transported back after knowing GM maize (Zerbe, 2004). 
They wanted GM maize which was milled to prevent 
contamination with domestic maize crop varieties (Cooke 
and Downie, 2010). On the other hand, Zambia wanted to 
mill maize to refugee camps that housed some Angolan 
and Congolese refugees. However, Zambian people 
were not allowed to consume it (Zerbe, 2004). The 
analysis of maize varieties collected from farms, 
household and research centres conducted in Cameroon 
proved the presence of genetic modified DNA, and 
probably the source could be from France, United States 
and South Africa which are the major sources of donated 
food (Roger and Gone, 2014). A case in point is the new 
B. thuringiensis-maize event called „Smartstax‟ that was 
recently registered for environmental release in the USA 





combines six insecticidal B. thuringiensis-toxins and 
resistance genes for two broad-spectrum herbicides. It 
entered the market with close to no testing for toxic or 
environmental impacts; it relied entirely on „the 
environmental risk assessment of the individual events‟, 
except for one additional study with an unspecified non-




HEALTH RISK OF GM MAIZE TO HUMANS AND 
ANIMALS 
 
Regarding the safety of GM crops and foods for humans‟ 
and animals‟ health, a comprehensive review of animal 
feeding studies of GM crops was found. An equilibrium in 
the number of research groups suggests that a number of 
varieties of GM products are mainly maize (Hilbeck et al., 
2015). The foreign protein synthesized from the 
transgene maize has an expected change and interaction 
in the new environment of a plant cell which may lead to 
alergenicity (Kosicka-Gębska et al., 2009). This is similar 
to Star Link maize which has been reported to cause food 
allergy (Taylor and Tick, 2001). In 2000, there were 
traces of Star Link maize, a GM maize variety approved 
for animals feed, but not for human consumption, 
because most of the consumers reported allergic 
reactions caused by eating taco shells. These studies 
were conducted by taking and analysing blood samples 
from the consumers. It was suggested that further studies 
be conducted to know if it affects animals (DeVilliers and 
Hoisington, 2011). According to the studies conducted in 
2001 by the Centers for Disease Control and Prevention, 
there is no evidence that exaggerated people 
experienced related allergic reaction after consuming 
Star Link maize (Ramjoue, 2008). From the reported 
information, there is enough evidence that Star Link 
maize is associated with risk to human and animals‟ 
health (Taylor and Tick, 2001). The Star Link producer 
incurred cost to compensate for those farmers who got 
losses due to the use of Star Link maize. This led to the 
rapid death of the company (Taylor and Tick, 2001). In 
order to prevent future problems of this nature, regulation 
needs to be established to reject GM maize which has 
not been authorized for animal and human consumption 
(Kiome, 2015). Other studies have reported long term-
effects in rats that consumed two Monsanto products, a 
GM maize and its associated pesticide, Roundup, 
together and separately (Spiroux de Vendômois et al., 
2009). The target parts of rat affected by GM maize 
containing Monsanto were liver and kidney (Spiroux de 
Vendômois et al., 2009). A study showed that rats fed for 
2 years with GM glyphosate-tolerant NK603 maize 
developed cancerous tumors (Seralini et al., 2014). 
Further studies have reported health risk of some GM 
maize to animals; for instance, a laboratory experiment 





pollen. It showed that pollen in maize rendered insect 
resistant through incorporation of a gene coding for a 
toxin from B. thuringiensis. This was toxic to larvae of the 
monarch butterfly (Losey et al., 1999). Several studies 
based on one type of toxin have been documented, for 
instance, Cry1Ab is present in GM maize varieties B. 
thuringiensis11 and MON810. A little is known about the 
toxicity of other types of B. thuringiensis toxin; for 
example Cry1F, present in the GM maize 1507 (Lang and 
Vojtech, 2006). Cry1F is highly likely to be toxic to non-
target organisms; however, there is need for further 
studies to confirm it (EFSA, 2011). Most B. thuringiensis 
maize produces toxin from their roots into the soil which 
is threat to other living organisms in the soil (Flores et al., 
2005). The long-term, cumulative effects of growing B. 
thuringiensis maize is toxic to aquatic organisms 
especially frog larvae and it affect plants which are useful 
for birds‟ survival (Zobiole et al., 2011a). Cry1Ab toxin is 
positive in human as it helps in rapid degradation in the 
human digestive system (Guimaraes et al., 2010). 
However, it contradicts recent studies which reported 
that, there is lack of degradation in the human gut. The 
toxin seems to have a greater potential to cause 
allergenic reactions (Guimaraes et al., 2010). This is in 
agreement with reported information of another recent 
study which found Cry1Ab B. thuringiensis toxin in the 
blood of pregnant women, and their foetuses showed the 
possibility of crossing the placental boundary (Aris and 





In conclusion, possible costs, benefits and risks 
associated with particular GM maize crops should be 
assessed only on a case by case basis. Any of such 
assessment needs to take into consideration a variety of 
factors, including the gene or combination of genes being 
inserted and the nature of the target maize crop. 
Considering whether GM maize crops should be used or 
not, it is important to focus on the specific situation in a 
particular country. All possible health risk to human, 
animals and environment should be taken into account 
before releasing new GM maize varieties. The cost-
effective, nutrition and the ability to afford an adequate 
diet should also be considered. Furthermore, research on 
the use of GM maize crop in developing countries should 
be sustained and governed by a reasonable application 
of the precautionary approach. There must be positive 
scientific results which address the current and future use 
of GM maize crops. The farmers‟ perspective and other 
stakeholders should be taken into consideration on 
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